ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,381.49
-0.42%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,415.91
-0.23%
Brent Oil
82.135
-0.38%
Bitcoin
69,967.41
-0.23%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Kazia Therapeutics Ltd (KZIA) Share Price

KZIA Kazia Therapeutics Ltd

0.2818
0.00 (0.00%)
Pre Market
Last Updated: 09:00:00
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Kazia Therapeutics Ltd NASDAQ:KZIA NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00 0.00 0.2818 0.27 0.29 0.00 0.00  1 08:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -20.47M - N/A 
 Type  Size  Price  Time  Units 
 9 1 0.28 08:11:52 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore KZIA News
17/05/202421:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
17/05/202421:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
01/05/202413:45PRNUSKAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
21/03/202412:52PRNUSKazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases
13/03/202412:00PRNUSKazia announces presentation of new data at AACR Annual Meeting
21/02/202421:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/02/202414:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Period
Draw mode
Data Downloads for KZIA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Kazia Therapeutics Ltd Articles